Kaufman MR, Peters KM, Chermansky CJ, et al. Iltamiocel cell therapy in women with recurrent or persistent stress urinary incontinence: evidence from two double-blind, randomized, placebo-controlled trials. Continence. 2025;14:101759. doi:10.1016/j.cont.2025.101759
Kaufman MR, Goldman HB, Chermansky CJ, et al. Iltamiocel autologous cell therapy for the treatment of female stress urinary incontinence: a double-blind, randomized, stratified, placebo-controlled trial. Neurourol Urodyn. Published online September 16, 2024. doi:10.1002/nau.25588
Knowles CH, Canestrari E, Jankowski RJ, Cardello K, Raval MJ. Safety and efficacy of Iltamiocel cellular therapy for the treatment of fecal incontinence: results of a phase 1/2 study. Ann Surg. 2023;278(6):937-944.
Nativ-Zeltzer N, Kuhn MA, Evangelista L, et al. Autologous muscle-derived cell therapy for swallowing impairment in patients following treatment for head and neck cancer. Laryngoscope. 2022;132(3):523-527. doi:10.1002/lary.29606
Gilleran J, Diokno AC, Ward E, et al. Improved global response outcome after intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder. Int Urol Nephrol. 2021;53(7):1331-1338. doi:10.1007/s11255-021-02847-1
Jankowski RJ, Tu LM, Carlson C, et al. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle-derived cells in female subjects with stress urinary incontinence. Int Urol Nephrol. 2018;50(12):2153-2165. doi:10.1007/s11255-018-2005-8
Chancellor MB, Bartolone SN, DeVries EM, et al. New technology assessment and current and upcoming therapies for underactive bladder. Neurourol Urodyn. 2018;37(8):2932-2937. doi:10.1002/nau.23738
Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle-derived cells for treatment of stress urinary incontinence in women. J Urol. 2014;192(2):469-476. doi:10.1016/j.juro.2014.02.047
Carr LK, Robert M, Kultgen PL, et al. Autologous muscle-derived cell therapy for stress urinary incontinence: a prospective, dose-ranging study. J Urol. 2013;189(2):595-601. doi:10.1016/j.juro.2012.09.028
Carr LK, Steele D, Steele S, et al. One-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):881-883. doi:10.1007/s00192-007-0553-z
